Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Jules, Mesnier"'
Autor:
Julio I. Farjat-Pasos, Jorge Nuche, Jules Mesnier, Vassili Panagides, Stephanie Cloutier, Christine Houde, Josep Rodés-Cabau
Publikováno v:
Journal of Stroke, Vol 24, Iss 3, Pp 335-344 (2022)
Transcatheter patent foramen ovale (PFO) closure is a safe and effective treatment for secondary prevention after a PFO-associated stroke as demonstrated in multiple large randomized clinical trials. However, these trials excluded a significant propo
Externí odkaz:
https://doaj.org/article/16f9a914492844eea048960f55494a5a
Autor:
Iria Silva, MD, Pierre Yves Turgeon, MD, Jean-Michel Paradis, MD, Jonathan Beaudoin, MD, Kim O’Connor, MD, Julien Ternacle, MD, PhD, Alberto Alperi, MD, Vassili Panagides, MD, Jules Mesnier, MD, Caroline Gravel, RN, Marie-Annick Clavel, DVM, PhD, François Dagenais, MD, Eric Dumont, MD, Siamak Mohammadi, MD, Philippe Pibarot, DVM, PhD, Mathieu Bernier, MD, Josep Rodés-Cabau, MD, Erwan Salaun, MD, PhD
Publikováno v:
Structural Heart, Vol 7, Iss 2, Pp 100114- (2023)
The use of transcatheter edge-to-edge mitral valve repair (TEER) in symptomatic patients with severe mitral regurgitation (MR) has dramatically increased over the last few years. Current guidelines consider TEER as a reasonable option in symptomatic
Externí odkaz:
https://doaj.org/article/5c88b929604f467e99fd0ffbd8ac8cd6
Autor:
Augustin Coisne, Josep Rodés-Cabau, Sebastian Ludwig, Andrea Scotti, Jules Mesnier, Torsten P. Vahl, Lauren S. Ranard, Michael C. Evans, Thomas Modine, Juan F. Granada
Publikováno v:
JACC: Cardiovascular Interventions. 16:1310-1312
Autor:
Josep Rodés-Cabau, Jules Mesnier
Publikováno v:
JACC: Clinical Electrophysiology. 9:677-679
Autor:
Paul Guedeney, Vincent Roule, Jules Mesnier, Celine Chapelle, Jean-Jacques Portal, Silvy Laporte, Edouard Ollier, Michel Zeitouni, Mathieu Kerneis, Niki Procopi, Olivier Barthelemy, Sabato Sorrentino, Michal Mihalovic, Johanne Silvain, Eric Vicaut, Gilles Montalescot, Jean-Philippe Collet
Publikováno v:
European Heart Journal - Cardiovascular Pharmacotherapy. 9:251-261
Aims As the antithrombotic regimen that may best prevent ischaemic complications along with the lowest bleeding risk offset following transcatheter aortic valve implantation (TAVI) remains unclear, we aimed to compare the safety and efficacy of antit
Autor:
Jorge Nuche, Vassili Panagides, Isabelle Nault, Jules Mesnier, Jean-Michel Paradis, Robert de Larochellière, Dimitri Kalavrouziotis, Eric Dumont, Siamak Mohammadi, Francois Philippon, Josep Rodés-Cabau
Publikováno v:
Heart Rhythm. 19:1890-1898
Transcatheter aortic valve replacement (TAVR) is well established for treating severe symptomatic aortic stenosis. Whereas broad information on the epidemiology, clinical implications, and management of bradyarrhythmias after TAVR is available, data
Autor:
Alberto Alperi, Mathieu Robichaud, Vassili Panagides, Jules Mesnier, Jorge Nuche, Jean-Michel Paradis, Robert Delarochelliere, Dimitri Kalavrouziotis, Eric Dumont, Siamak Mohammadi, Josep Rodés-Cabau
Publikováno v:
International Journal of Cardiology. 366:90-96
High (≥20 mmHg) postprocedural mean transvalvular gradients are relatively common among valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) recipients, but its clinical impact remains controversial.Observational study including 190 c
Autor:
Paul Guedeney, Jules Mesnier, Michel Zeitouni, Marie Hauguel-Moreau, Johanne Silvain, Christine Houde, Alberto Alperi, Vassili Panagides, Jean-Philippe Collet, Thomas Wallet, Stéphanie Rouanet, Nadjib Hammoudi, Josep Rodés-Cabau, Gilles Montalescot
Publikováno v:
Canadian Journal of Cardiology. 38:1228-1234
Background Randomized controlled trials evaluating patent foramen ovale (PFO) percutaneous closure only included patients with recent embolic event. We aimed to evaluate outcomes following percutaneous PFO closure outcomes according to the delay from
Autor:
Jules Mesnier, Pedro Cepas-Guillén, Xavier Freixa, Eduardo Flores-Umanzor, Kim Hoang Trinh, Gilles O’Hara, Josep Rodés-Cabau
Publikováno v:
Circulation: Cardiovascular Interventions. 16
Left atrial appendage closure is an alternative to chronic oral anticoagulation to prevent embolic events related to nonvalvular atrial fibrillation. After device implantation, antithrombotic treatment is prescribed to prevent device-related thrombos
Autor:
Vassili Panagides, Dimitri Kalavrouziotis, Eric Dumont, Robert Delarochellière, Jean-Michel Paradis, Jules Mesnier, Siamak Mohammadi, Josep Rodés-Cabau
Publikováno v:
International Journal of Cardiology. 358:12-16
Transcarotid (TC) is a common alternative access for transcatheter aortic valve replacement (TAVR) when the transfemoral route is not suitable. However, scarce data exist on systematic ultrasound (US) follow-up of these patients. This study aims to e